Form D · Biotechnology
Mesa Biotech, Inc.
San Diego, CA · CIK 0001675100
Offering snapshot reported Oct 29, 2019 · SEC filing
- Reported sold
- $3M Offering amount: $20M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 24, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 29, 2019 | Initial | $2,999,997 | No comparison | 1 | SEC filing |
| Jul 10, 2018 | Initial | $11,999,996 | No comparison | 1 | SEC filing |
| Feb 22, 2018 | Initial | $3,001,413 | No comparison | 1 | SEC filing |
| Dec 1, 2017 | Initial | $795,152 | No comparison | 1 | SEC filing |
| May 23, 2016 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-352053
Source: Form D, filed Oct 29, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William Brody | Director |
| Hong Cai | Director, Executive |
| Robert Bruce Cary | Director, Executive |
| R. Bruce Cary | Director |
| Wen Chen | Director |
| Eric Sagerman | Director |
| Tom Willardson | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6190 Cornerstone Court E Suite 220
San Diego, CA, 92121
San Diego, CA, 92121